News | November 09, 2008

GE Healthcare Launches Vivid E9, Vivid q, Intracardiac Echo at AHA

November 10, 2008 - GE Healthcare launched three new cardiac ultrasound devices for the U.S. market to aid 4D heart imaging and quantitative analysis at the 2009 meeting of the American Heart Association.

Ten years ago, GE acquired Diasonics Vingmed Ultrasound Ltd., creating the Vivid family of cardiovascular ultrasound products. At the time, the idea of even capturing a full-volume 4D cardiac image remained out of reach. Today, GE offers it on the all-new Vivid E9 in a single heartbeat. The company said this was made possible by the Vivid E9’s new engine, which is eight times more powerful than its predecessor. Its 4D Virtual Store uses image pointers to help users better manage the large data sets 4D imaging provides. With the push of a button, “One touch Easy 4D” automatically crops away the full volume and gives the user the requested view.

The Vivid E9 marks GE’s maiden voyage into true 4D stress echo, the company said. Using new scan assist technology, users can acquire single cycle or multi cycle full volumes in any variation of traditional, multi dimensional or full volume views. Vivid E9’s templates for both exercise and pharmacologic stress tests are all fully customizable, GE stated.

Vivid E9’s Accelerated Volume Architecture (AVA) makes single beat acquisition possible, and alongside extended signal transducer technology in each probe, it delivers a leap in 2D, 4D and shared service image quality, the company said.
The new M5S transducer takes the matrix array technology and marries this with single crystal technology to reportedly provide better endocardial definition, texture, and crisper valves across a wider range of frequencies than traditional transducers.

The Vivid E9 is also 40 percent smaller and 30 percent lighter than the Vivid 7. It also has a one touch access for the electronic keyboard and touch panel and another touch adjusts the height and position, instantly.

GE also announced at AHA the delivery of the 5,000th unit in the Vivid compact ultrasound family. GE engineers said they took the advanced features of Vivid i and expanded them with enhanced exceptional imaging and new quantification tools. The result is the all-new Vivid q cardiovascular ultrasound system for portable echocardiography. It can be used to diagnose cardiovascular anatomy and LV.

The Vivid q features new image quality enhancements migrated from the Vivid 7, including the M4S transducer. The matrix probe technology with the M4S transducer allows electronic beam focusing in three dimensions, enabling higher image quality levels, the company said.

Designed specifically for the Vivid q, AutoEF is a new automated ejection fraction measurement program that works alongside the AFI (automated function imaging) feature, migrated from Vivid 7. Tissue synchronization imaging (TSI) including quantitative analysis represents parametric imaging modes to help physicians see quantitative information in moving two-dimensional images.

GE’s Vivid i and Vivid q systems now offer intracardiac echo (ICE) technology, providing real-time image guidance and visualization of anatomical structures to help clinicians increase their confidence when performing complex electrophysiology and interventional cardiology procedures.

For more information: www.gehealthcare.com

Related Content

Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
Epsilon Imaging Demonstrates Strain Imaging Integration for Echo Programs at ASE 2018
News | Cardiovascular Ultrasound | June 19, 2018
Clinical practice, along with guidelines and research, have shown that speckle tracking strain imaging can improve...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
Hitachi Medical Systems Europe Named Imaging Supplier for London Prostate Cancer Program
News | Prostate Cancer | June 14, 2018
Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part of the RAPID...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
Olympus and Hitachi Healthcare Americas Introduce Arietta 850
News | Ultrasound Imaging | June 04, 2018
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedu
New Ultrasound Guidelines Reliably Identify Children Who Should be Biopsied for Thyroid Cancer

Image courtesy of Loyola Medicine

News | Pediatric Imaging | May 29, 2018
A Loyola Medicine study has found that new ultrasound guidelines can reliably identify pediatric patients who should be...
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | Angiography | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
Overlay Init